Additional Information

Description

Exparel 1.3% 266mg/20ml DS 10B is a specialized formulation of bupivacaine, a long-acting local anesthetic used to manage postoperative pain. It is designed for single-dose infiltration into surgical sites to provide extended pain relief over several days. This formulation utilizes a liposomal delivery system, where bupivacaine molecules are encapsulated within lipid membranes, allowing for slow and controlled release into the surrounding tissues.

Used predominantly in surgical settings, Exparel helps reduce the need for opioids postoperatively by providing sustained pain relief directly at the site of surgery. This targeted approach minimizes systemic side effects associated with traditional pain management methods while improving patient comfort and recovery outcomes.

The 1.3% concentration denotes the amount of bupivacaine per volume (266mg per 20ml), ensuring a potent yet safe dosage for effective pain control. Each vial (DS 10B) is prepared for single-use administration, adhering to stringent safety protocols and minimizing the risk of contamination or misuse.